Fatigue and energy levels : Fatigue is a common adverse effect listed in the UK SmPC for Saxenda
While taking Semaglutide GLP-1, essentially suppresses appetite through GLP-1 receptor antagonists binding GLOP-1 receptors in the brain
Peptides can also undergo post-translational modifications, such as phosphorylation, glycosylation, and ubiquitination, which can affect their function and stability
These gains matter most for tendon, ligament, and muscle injuries, where tissue quality directly affects function
and psychological factors (e.g., anxiety, depression) and genetic susceptibility also play an important role in the development of insomnia